Schweiger Dermatology has secured a $20 million debt facility from Triangle Capital to help fund and support its growth.

Under the terms of this facility, the total funding may be increased to $30 million in the near term and has the potential to grow to $50 million over the life of the facility. The capital will be deployed by SDG to continue with its de novo expansion and acquisition strategy in the Northeast. With more than 20 locations in the New York metro area, Schweiger Dermatology Group continues to expand and break new ground in the field of dermatology.

“We are focused on creating the ultimate patient experience, which consists of providing convenient access to top dermatology providers in the greater New York metropolitan area, in state of the art facilities,” said Dr. Eric Schweiger, founder and CEO of SDG. “We are excited to partner with TCAP, which will help us to deliver our vision of modern dermatological care to even more patients.”

James Burke, managing director at TCAP, said, “We have been impressed with the platform and team that Dr. Schweiger has built to date and we look forward to supporting the company as it continues to expand its footprint

Triangle Capital invests capital in established companies in the lower middle market to fund growth, changes of control and other corporate events. Triangle offers a wide variety of investment structures with a primary focus on mezzanine financing with equity components.